Skip to content

XOMA Corporation XOMA Return on assets

Return on assets at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
12.6%+8.2pp
Royalty Pharma logo
Royalty PharmaRPRX
4.4%-2.1pp
Theravance Biopharma logo
Theravance BiopharmaTBPH
28.1%+20.5pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
32.6%+29.0pp
Zymeworks logo
ZymeworksZYME
-22.7%-0.5pp
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-46.7%+6.0pp

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$745.16M+159%
Enterprise value$784.29M+152%
P/E22×
P/S15.4×+8.6×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Calculated from XOMA Corporation’s reported figures.

Based on trailing twelve months.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's return on assets?
XOMA Corporation (XOMA) reported return on assets of 14% in Q1 2026.
How has XOMA Corporation's return on assets changed year-over-year?
XOMA Corporation's return on assets increased by 1154.6% year-over-year, from -1.3% to 14%.
What is the long-term trend for XOMA Corporation's return on assets?
Over 5 years (2020 to 2025), XOMA Corporation's return on assets has grown at a 1.3% compound annual growth rate (CAGR), from 12% to 12.8%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.